Contract 0000399266

McKesson Medical has been awarded a Texas state and local contract (0000399266) effective April 2, 2026, for the supply of pharmaceutical products classified as skin and mucous membrane agents. The contract encompasses multiple line items (12, 15, 21, 22, 23, 26, 33, 39, 41, 42, 48, 49, and 50) under requisition MIM2614738 and covers a range of dermatological and antifungal medications.

The deliverables under this contract include combination keratolytics and caustics, antifungal amides, antifungal peptides, synthesized antifungals, and combination antifungal formulations, as identified by United Nations Standard Products and Services Code (UNSPSC) classifications 51242000, 51301700, 51302100, 51303200, and 51303600 respectively. These products fall under the National Institute of Governmental Purchasing (NIGP) category for Skin and Mucous Membrane Agents (NIGP Code 26984). Specific contract value, period of performance, and organizational procurement details are not available in the provided documentation.